Rare Diseases Trial Network Moves Closer to Reality

As many as 30 million Americans may be living with a “rare disease,” officially defined as a condition affecting fewer than 200,000 people.

The Genetic and Rare Diseases Information Center says there are some 7,000 known rare diseases. Most are genetic. Only about 10% of all rare diseases have an approved treatment.

To hasten the development of drugs and therapies, the Food and Drug Administration in 2019 began an initiative to “to facilitate a cooperative approach and common standardized platforms to better characterize rare diseases, incorporate the patient’s perspective in clinical outcome assessment measures, and build clinical trial readiness in the pre-competitive space.”

Dubbed the Rare Disease Cures Accelerator, the initial focus of the program is building “an integrated database and analytics hub designed to promote the secure sharing of existing patient-level data and encourage the standardization of new data collection.”

A second key part was to award grants “develop standard core sets of clinical outcome assessments (COAs) and endpoints for specific disease indications.”

In May, the FDA asked for input from industry, rare disease organizations, patients and others regarding the “implementation and sustainment of global clinical trials networks.”

“As drug development for rare diseases can be challenging due to the small number of patients and limited understanding of the variability and progression of the diseases, the FDA is committed to developing bold new approaches to harness the infrastructure of global clinical trial networks,” said Anand Shah, FDA deputy commissioner for medical and scientific affairs.

A recent report on Regulatory Focus, the website of the Regulatory Affairs Professionals Society, said the stakeholders who commented “called for regulatory clarity, smart use of existing resources, and a move toward harmonized trial standards and assessments.”

Several comments addressed the need to ensure the quality of the data collected as well as reducing and eliminating some of the challenges unique to rare disease trials.

On behalf of the Biotechnology Innovation Organization, Danielle Friend, senior director of science and regulatory affairs, said the networks need to support “the collection of high-quality data that are endorsed by the agency for regulatory decision-making.” She said a rare disease network must recognize and address “heterogeneity in rare diseases, lack of harmonization among global regulators in rare disease regulatory policy, and current inconsistencies in clinical trial network operation.” The FDA plan also should consider combining rare diseases into a single trial when possible.

The National Organization for Rare Diseases echoed those comments, and, according to Regulatory Focus, said “Increased collaboration and a focus on increasing the speed and success of clinical trials can have the effect of ‘breaking down the silos of activity currently taking place in rare disease research.’”

Now the FDA will analyze the comments, incorporating them into a development plan for its trials networks program. No timeline was given for this phase of the program.

Photo by CDC on Unsplash

#WeAreGreenKey: Spotlight on Justin Stratton
Creative General Interest Green Key News Human Resources Professional Support Worklife

#WeAreGreenKey: Spotlight on Justin Stratton

Director of Green Key Pharma Receives RAPS’ Community Leadership Award
General Interest Green Key News Healthcare Leadership + Management Pharma Worklife

Director of Green Key Pharma Receives RAPS’ Community Leadership Award

5 Tips to Ace Your Virtual Interview
Accounting + Finance Architecture + Engineering Creative Financial Services General Interest Healthcare Human Resources Information Technology Leadership + Management Legal Support Marketing Technology Pharma Professional Support

5 Tips to Ace Your Virtual Interview

#WeAreGreenKey: Spotlight on Clare Wright
General Interest Green Key News Professional Support Worklife

#WeAreGreenKey: Spotlight on Clare Wright

Green Key Unlocked: The Future of Administrative Support
General Interest Green Key News Human Resources Professional Support Worklife

Green Key Unlocked: The Future of Administrative Support

#WeAreGreenKey: Spotlight on Tara Potter
General Interest Green Key News Pharma

#WeAreGreenKey: Spotlight on Tara Potter

Green Key Unlocked: Hiring Trends in Architecture, Engineering, and Construction
Architecture + Engineering General Interest Green Key News

Green Key Unlocked: Hiring Trends in Architecture, Engineering, and Construction

#WeAreGreenKey: Spotlight on Shandi Frederick
General Interest Green Key News Healthcare

#WeAreGreenKey: Spotlight on Shandi Frederick

#GreenKeyUnlocked: What’s New in the Tech Job Market?
General Interest Green Key News Information Technology

#GreenKeyUnlocked: What’s New in the Tech Job Market?

#WeAreGreenKey: Spotlight on Jordan Boyd
General Interest Green Key News Information Technology

#WeAreGreenKey: Spotlight on Jordan Boyd

How to Negotiate a Job Offer
General Interest Worklife

How to Negotiate a Job Offer

#GreenKeyUnlocked: Digital Tools and Technologies in Pharma
General Interest Green Key News Healthcare Marketing Technology Pharma

#GreenKeyUnlocked: Digital Tools and Technologies in Pharma

#WeAreGreenKey: Spotlight on Jordan Haas
General Interest Green Key News Pharma

#WeAreGreenKey: Spotlight on Jordan Haas

#GreenKeyUnlocked: Become a Medical Assistant
General Interest Green Key News Healthcare

#GreenKeyUnlocked: Become a Medical Assistant

#WeAreGreenKey: Intern Spotlight on Olivia Stein
General Interest Green Key News Healthcare Worklife

#WeAreGreenKey: Intern Spotlight on Olivia Stein

#WeAreGreenKey: Spotlight on Brett Braterman
General Interest Green Key News Healthcare

#WeAreGreenKey: Spotlight on Brett Braterman

#GreenKeyUnlocked: Accounting Advisory Consulting
Accounting + Finance Financial Services

#GreenKeyUnlocked: Accounting Advisory Consulting

#GreenKeyUnlocked: Let’s Get Creative!
Creative General Interest Green Key News

#GreenKeyUnlocked: Let’s Get Creative!

How to Quit Your Job (The Right Way)
General Interest Worklife

How to Quit Your Job (The Right Way)

Green Key Unlocked: Let’s Talk Marketing Operations
General Interest Green Key News Information Technology Marketing Technology

Green Key Unlocked: Let’s Talk Marketing Operations

Latest Blog Posts
View All Posts
#WeAreGreenKey: Spotlight on Justin Stratton

#WeAreGreenKey: Spotlight on Justin Stratton

Justin Stratton joined Green Key Resources as an Executive Recruiter in 2015. Six years later, he is a Staffing Manager...
Read More
Director of Green Key Pharma Receives RAPS’ Community Leadership Award

Director of Green Key Pharma Receives RAPS’ Community Leadership Award

Director of Green Key Pharma, Lindsey Summers, is a co-recipient of the Regulatory Affairs Professional Society (RAPS) 2021 Community Leadership...
Read More
5 Tips to Ace Your Virtual Interview

5 Tips to Ace Your Virtual Interview

Whether you’re preparing for a phone screen or a final stage interview, virtual interviews are now an inevitable component of...
Read More